Featured Research

from universities, journals, and other organizations

Breakthrough technology enables gene silencing to heal wounds

January 17, 2014
National Institute of Biomedical Imaging and Bioengineering
Researchers have developed a tissue scaffold that can deliver gene therapy to wounds over a period of several weeks.

Micro-CT images of blood vessels growing within tissue scaffolds implanted in mice. Blood vessel volume increased threefold in tissue scaffolds that delivered PHD2- silencing molecules to nearby cells.
Credit: Image courtesy of Craig Duvall, Ph.D., Vanderbilt University

A team of researchers led by an NIBIB grantee at Vanderbilt University has created a biodegradable scaffold that enables sustained, local delivery of gene-silencing factors called siRNA to promote tissue regeneration. The team recently used the scaffold to successfully deliver siRNA to mice in order to locally silence a gene normally responsible for inhibiting blood vessel formation.

Related Articles

The technology could provide a new approach for the treatment of chronic wounds, which afflict over six million patients in the U.S. and cost an estimated $25 billion dollars per year to treat. Because diabetic patients are at increased risk for developing chronic wounds, these numbers are expected to rise as diabetes rates climb.

Using gene silencing to heal wounds

Blood vessels deliver important factors to wounds, such as oxygen, micronutrients, and growth factors. Studies suggest that increasing angiogenesis -the formation of new blood vessels -- may help to heal wounds.

One way to enhance the development of blood vessels is through the delivery of growth factors directly to wounds; yet multiple growth factors are needed to produce mature blood vessels, and their concentration as well as the timing of their application must be carefully orchestrated to facilitate proper growth.

An alternative approach involves delivering siRNA -- short, double-stranded RNA molecules designed to silence a gene of interest -- to cells in order to influence genes that induce the formation of new blood vessels. While this method also ultimately results in an increase in pro-angiogenic growth factors, this approach leverages natural mechanisms in the cell that produce a symphony of related factors, initiating a robust "growth program" that induces formation of mature, stable vasculature.

Yet, delivering a sufficient amount of siRNA to cells is a notoriously difficult task, one that has prevented this therapy from being adopted clinically for wound healing.

"Many biologic drugs such as siRNA exhibit transient activity," said Craig Duvall, Ph.D., Assistant Professor of Biomedical Engineering at Vanderbilt University, who led the study. "This is especially true in sites where cells are rapidly dividing, as is the case in wounds. Every time those cells divide, the siRNA effectively gets diluted out. So, with a single dose of siRNA, you may achieve activity for only a few days."

A new technology for siRNA delivery

In a manuscript published online in December 2013 in Advanced Materials, Duvall and colleagues reported the use of a novel tissue scaffold that can deliver siRNA to nearby cells over a period of several weeks. Using an siRNA dose 10-100-fold lower than previous studies, the research team efficiently silenced the expression of PHD2 -- a protein that normally inhibits blood vessel formation -- locally within a biodegradable tissue scaffold. At 33 days post-implant, the scaffolds that delivered PHD2 siRNA had a three-fold increase in the volume of local blood vessels.

To achieve sustained delivery, the researchers first packaged siRNA into nanoparticles, which protect siRNA from being degraded by enzymes found in the extracellular environment. They then combined these nanoparticles with varying amounts of a substance called trehalose. This nanoparticle-trehalose combination was then embedded into a biodegradable tissue scaffold, which they implanted under the skin of a mouse. Trehalose acts as a porogen, meaning it creates pores in the tissue scaffold. As a result, the rate at which nanoparticles are released from the scaffold is directly influenced by the amount of trehalose added. Based on the quantity of trehalose, the system can be tuned to release the nanoparticles to the surrounding cells immediately or over a period of several weeks.

Duvall says their scaffold provides the unique ability to adapt siRNA treatment to fit a particular clinical problem. "Depending on the target gene, and its time course of expression during the wound healing process, you may want to have a fast, short-lived silencing effect, or you may want to have a long-term, sustained silencing effect. For example, in a hard to close wound, you may want to deliver siRNA for a month, or even longer. With this scaffold, we can make that adjustment by simply tuning the quantity of trehalose."

Christine A. Kelley, Ph.D., a Division Director at the NIBIB, praised the development saying, "This innovative approach and effective method for local siRNA delivery could have wide applications including diabetic wound healing, a significant and growing problem across the globe."

What's next?

Duvall and his team are now planning to test the efficacy of their scaffold in closing wounds of diabetic rats. In the future, they also plan to explore siRNA treatments targeting different genes for both wound healing and other types of conditions.

"What we've developed is a platform technology," said Duvall. "One of the nice things about siRNA is that you can design it with high specificity against any target you want. That opens up a whole universe of opportunities in terms of therapeutic intervention both for wounds and for other types of pathological and tissue regenerative applications."

Duvall says he is also currently working to simplify the method for creating the scaffold so that it can be more easily and inexpensively made on larger scales. He plans to continue testing the scaffold in larger animals and hopes it will be ready to test in humans in five years.

Story Source:

The above story is based on materials provided by National Institute of Biomedical Imaging and Bioengineering. Note: Materials may be edited for content and length.

Journal Reference:

  1. Christopher E. Nelson, Arnold J. Kim, Elizabeth J. Adolph, Mukesh K. Gupta, Fang Yu, Kyle M. Hocking, Jeffrey M. Davidson, Scott A. Guelcher, Craig L. Duvall. Tunable Delivery of siRNA from a Biodegradable Scaffold to Promote Angiogenesis In Vivo. Advanced Materials, 2013; DOI: 10.1002/adma.201303520

Cite This Page:

National Institute of Biomedical Imaging and Bioengineering. "Breakthrough technology enables gene silencing to heal wounds." ScienceDaily. ScienceDaily, 17 January 2014. <www.sciencedaily.com/releases/2014/01/140117103921.htm>.
National Institute of Biomedical Imaging and Bioengineering. (2014, January 17). Breakthrough technology enables gene silencing to heal wounds. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2014/01/140117103921.htm
National Institute of Biomedical Imaging and Bioengineering. "Breakthrough technology enables gene silencing to heal wounds." ScienceDaily. www.sciencedaily.com/releases/2014/01/140117103921.htm (accessed December 19, 2014).

Share This

More From ScienceDaily

More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins